References
- Korean Network for Organ Sharing (KONOS)2016 Annals of Transplantation Statistics SeoulKoreaKorean Network for Organ Sharing, Korea Centers for Disease Control & Prevention2017
- KimWRLakeJRSmithJMOPTN/SRTR 2016 Annual Data Report: LiverAm J Transplant201818Suppl 117225329292603
- JiEChoiLSuhKSChoJYHanNOhJMCombinational effect of intestinal and hepatic CYP3A5 genotypes on tacrolimus pharmacokinetics in recipients of living donor liver transplantationTransplantation201294886687222992768
- LuceyMRTerraultNOjoLLong-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of TransplantationLiver Transpl201319132623281277
- European Association for the Study of the LiverEASL Clinical Practice Guidelines: Liver transplantationJ Hepatol201664243348526597456
- ShukerNvan GelderTHesselinkDAIntra-patient variability in tacrolimus exposure: causes, consequences for clinical managementTransplant Rev20152927884
- StaatzCETettSEClinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantationClin Pharmacokinet2004431062365315244495
- ScottLJMckeageKKeamSJPloskerGLTacrolimus: a further update of its use in the management of organ transplantationDrugs200363121247129712790696
- JuskoWJThomsonAWFungJConsensus document: therapeutic monitoring of tacrolimus (FK-506)Ther Drug Monit19951766066148588229
- WallemacqPArmstrongVWBrunetMOpportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conferenceTher Drug Monit200931213915219177031
- BrooksETettSEIsbelNMStaatzCEPopulation Pharmacokinetic Modelling and Bayesian Estimation of Tacrolimus Exposure: Is this Clinically Useful for Dosage Prediction Yet?Clin Pharmacokinet201655111295133527138787
- LeeJYHahnHJSonIJFactors affecting the apparent clearance of tacrolimus in Korean adult liver transplant recipientsPharmacotherapy20062681069107716863483
- YuKSChoJYJangIJEffect of the CYP3A5 genotype on the pharmacokinetics of intravenous midazolam during inhibited and induced metabolic statesClin Pharmacol Ther200476210411215289787
- YangJWLiaoSSZhuLQPopulation pharmacokinetic analysis of tacrolimus early after Chinese pediatric liver transplantationInt J Clin Pharmacol Ther2015531758325207550
- ZhuLYangJZhangYJingYZhangYLiGEffects of CYP3A5 genotypes, ABCB1 C3435T and G2677T/A polymorphism on pharmacokinetics of Tacrolimus in Chinese adult liver transplant patientsXenobiotica201545984084625869250
- DutkowskiPde RougemontOMüllhauptBClavienPACurrent and future trends in liver transplantation in EuropeGastroenterology20101383e804802809
- IngulliEMechanism of cellular rejection in transplantationPediatr Nephrol2010251617421476231
- FukudoMYanoIFukatsuSForecasting of blood tacrolimus concentrations based on the Bayesian method in adult patients receiving living-donor liver transplantationClin Pharmacokinet200342131161117814531726
- LiDLuWZhuJYGaoJLouYQZhangGLPopulation pharmacokinetics of tacrolimus and CYP3A5, MDR1 and IL-10 polymorphisms in adult liver transplant patientsJ Clin Pharm Ther200732550551517875118
- ChenBShiHQLiuXXPopulation pharmacokinetics and Bayesian estimation of tacrolimus exposure in Chinese liver transplant patientsJ Clin Pharm Ther201742667968828833329
- FukudoMYanoIYoshimuraAImpact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patientsPharmacogenet Genomics200818541342318408564
- SchianoTDKim-SchlugerLGondolesiGMillerCMAdult living donor liver transplantation: the hepatologist’s perspectiveHepatology20013313911124813
- AntignacMHulotJSBoleslawskiEPopulation pharmacokinetics of tacrolimus in full liver transplant patients: modelling of the postoperative clearanceEur J Clin Pharmacol2005615–640941615991041
- FukatsuSYanoIIgarashiTPopulation pharmacokinetics of tacrolimus in adult recipients receiving living-donor liver transplantationEur J Clin Pharmacol2001576–747948411699612
- Macchi-AndansonMCharpiatBJelliffeRWDucerfCFourcadeNBaulieuxJFailure of traditional trough levels to predict tacrolimus concentrationsTher Drug Monit200123212913311294512
- OteoILukasJCLealNTacrolimus pharmacokinetics in the early post-liver transplantation period and clinical applicability via Bayesian predictionEur J Clin Pharmacol20136916574
- ValdiviesoNOteoIValdiviesoATacrolimus dose individualization in “de novo” patients after 10 years of experience in liver transplantation: pharmacokinetic considerations and patient pathophysiologyInt J Clin Pharmacol Ther201351760661423735178
- MoesDJvan der BentSASwenJJPopulation pharmacokinetics and pharmacogenetics of once daily tacrolimus formulation in stable liver transplant recipientsEur J Clin Pharmacol201672216317426521259
- AllowayRRDupuisRGabardiSEvolution of the role of the transplant pharmacist on the multidisciplinary transplant teamAm J Transplant20111181576158321672154
- Organ Procurement and Transplantation Network and Scientific Registry of Transplant RecipientsOPTN/SRTR 2012 Annual Data ReportRockville, MDDepartment of Health and Human Services, Health Resources and Services Administration Healthcare Systems Bureau, Division of Transplantation2014
- Korean Society of Health-System Pharmacists (KSHP)Guide For Pharmacy SpecialistsSeoul, KoreaKorean Society of Health-System Pharmacists2015